Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02303041
Title Erismodegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Stanford University
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University School of Medicine Stanford California 94305 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field